Home

Aisling Capital Partners III LLC

CIK 1532635 · last filed 2018-07-12

Aisling Capital Partners III LLC is a corporate insider who has filed 7 SEC Form 4 insider transactions across 3 companies since 2013. The most recent filing shows the insider sold $1.51B of LOXO on Jul 12, 2018. Across all open-market trades the lifetime net is −$1.84B, making them a net seller over the disclosed history. The firm reports its address in New York, NY. 34 SEC filings were submitted jointly with AISLING CAPITAL III LP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

7

Lifetime Open-Market Net

-$1.84B

Filer Profile

Reported Address
AISLING CAPITAL LLC
888 SEVENTH AVENUE 30TH FLOOR
NEW YORK, NY 10106
Phone
(212) 651-6380
State of Incorporation
DE
Related Filers
AISLING CAPITAL III LP — 34 joint filings, latest 2018-07-12
Aisling Capital Partners III LP — 34 joint filings, latest 2018-07-12
STEVE ELMS — 34 joint filings, latest 2018-07-12
Dennis J Purcell — 34 joint filings, latest 2018-07-12
ANDREW N SCHIFF — 34 joint filings, latest 2018-07-12
Zeltiq Aesthetics Inc — 4 joint filings, latest 2014-01-27
DOV A MD GOLDSTEIN — 2 joint filings, latest 2014-08-06
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Loxo Oncology, Inc. (LOXO) Delisted 10%+ Owner 2,038,920 — — -$1.79B 5 2018-07-12
AGILE THERAPEUTICS INC (AGRX) Delisted 10%+ Owner 1,292 $1.51 $2.0K $0 1 2016-06-03
Zeltiq Aesthetics Inc (ZLTQ) Delisted 10%+ Owner 3,597,742 — — -$42.16M 1 2013-11-15

Recent Filings

7 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2018-07-12 Loxo Oncology, Inc. (LOXO) Delisted Sell (S) −8,400,000 -$1.51B EDGAR
2017-12-20 Loxo Oncology, Inc. (LOXO) Delisted Sell (S) −1,500,000 -$120.75M EDGAR
2017-11-27 Loxo Oncology, Inc. (LOXO) Delisted Sell (S) −3,000,000 -$225.00M EDGAR
2017-01-12 Loxo Oncology, Inc. (LOXO) Delisted Buy (P) +960,000 $29.76M EDGAR
2016-06-03 AGILE THERAPEUTICS INC (AGRX) Delisted Other (J) −2,400,000 $0 EDGAR
2016-05-19 Loxo Oncology, Inc. (LOXO) Delisted Buy (P) +1,395,348 $30.00M EDGAR
2013-11-15 Zeltiq Aesthetics Inc (ZLTQ) Delisted Sell (S) −3,450,000 -$42.16M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.